hypertensive
Replacement of angiotensin-converting enzyme inhibitors by       angiotensin-II-receptor antagonists in hypertensive patients with type II       diabetes mellitus: metabolic and hemodynamic consequences.
Replacement of angiotensin-converting enzyme inhibitors by       angiotensin-II-receptor antagonists in  @SUBJECT$  @PREDICAT$  @OBJECT$  with type II       diabetes mellitus: metabolic and hemodynamic consequences.